메뉴 건너뛰기




Volumn 72, Issue 24, 2012, Pages 6319-6324

A blueprint for an international cancer epigenome consortium. A report from the AACR cancer epigenome task force

(12)  Beck, Stephan a   Bernstein, Bradley E b   Campbell, Robert M d   Costello, Joseph F e   Dhanak, Dashyant h   Ecker, Joseph R f   Greally, John M j   Issa, Jean Pierre i   Laird, Peter W g   Polyak, Kornelia c   Tycko, Benjamin k   Jones, Peter A g  


Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; ENTINOSTAT; ROMIDEPSIN; VORINOSTAT;

EID: 84871232475     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-3658     Document Type: Short Survey
Times cited : (22)

References (3)
  • 1
    • 84863770814 scopus 로고    scopus 로고
    • Cancer genetics and epigenetics: Two sides of the same coin?
    • Yoo JS, Jones PA. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 2012;22:9-20.
    • (2012) Cancer Cell , vol.22 , pp. 9-20
    • Yoo, J.S.1    Jones, P.A.2
  • 2
    • 84655163371 scopus 로고    scopus 로고
    • Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer
    • Juergens RA, Wrangle J, Vendetti FP, Murphy SC, Zhao M, Coleman B, et al. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov 2011;1:598-607.
    • (2011) Cancer Discov , vol.1 , pp. 598-607
    • Juergens, R.A.1    Wrangle, J.2    Vendetti, F.P.3    Murphy, S.C.4    Zhao, M.5    Coleman, B.6
  • 3
    • 79952384705 scopus 로고    scopus 로고
    • Cancer epigenetics reaches mainstream oncology
    • Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011;17:330-9.
    • (2011) Nat Med , vol.17 , pp. 330-339
    • Rodriguez-Paredes, M.1    Esteller, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.